Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × SCLC × Drug Therapy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 122 Breast Neoplasms 62 Colorectal Neoplasms 56 Neoplasms 45 Lung Neoplasms 39 Stomach Neoplasms 38 Pancreatic Neoplasms 38 Neoplasm Metastasis 38 Ovarian Neoplasms 37 Rectal Neoplasms 36 Esophageal Squamous Cell Carcinoma 31 Squamous Cell Carcinoma of Head and Neck 27 Head and Neck Neoplasms 26 Esophageal Neoplasms 26 Leukemia, Myeloid, Acute 22 Recurrence 20 Triple Negative Breast Neoplasms 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Nasopharyngeal Carcinoma 18 Glioblastoma 17 Fallopian Tube Neoplasms 17 Small Cell Lung Carcinoma 16 Prostatic Neoplasms 16 Lymphoma, Non-Hodgkin 16 Uterine Cervical Neoplasms 15 Lymphoma 15 Colonic Neoplasms 15 Carcinoma, Squamous Cell 14 Sarcoma 13 Leukemia 12

Interventions

Paclitaxel 2 Etoposide 2 Carboplatin 2 sintilimab 1 atezolizumab 1 apatinib 1 Topotecan 1 Platinum 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡